Journal articles
Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Goldstein D; Kiernan MC, 2008, 'Oxaliplatin-induced chronic changes in sensory nerve excitability', Clinical Neurophysiology, 119, pp. e22 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.044
Yang JL; Qu X; Yu Y; Kohn E; Friedlander ML, 2008, 'Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency', International Journal of Cancer, 123, pp. 258 - 263, http://dx.doi.org/10.1002/ijc.23535
Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PDP; Webb PM; Chenevix-Trench G; Bowtell D; Green A; DeFazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes L; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; Beale P; Beith J; Carter J; Dalrymple C; Hamilton A; Houghton R; Russell P; Brand A; Jaworski R; Harnett P; Wain G; Crandon A; Cummings M; Horwood K; Obermair A; Wyld D; Nicklin J; Perrin L; Ward B; Davy M; Hall C; Dodd T; Healy T; Pittman K; Henderson D; Hyde S; Miller J; Pierdes J; Blomfield P; Challis D; McIntosh R; Parker A, 2007, 'Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: Results from two Australian studies and an additional validation set', Cancer Epidemiology Biomarkers and Prevention, 16, pp. 2557 - 2565, http://dx.doi.org/10.1158/1055-9965.EPI-07-0542
Olsen CM; Bain CJ; Jordan SJ; Nagle CM; Green AC; Whiteman DC; Webb PM; Bowtell D; Chenevix-Trench G; Green A; Defazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes L; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; Beale P; Beith J; Carter J; Dalrymple C; Hamilton A; Houghton R; Russell P; Brand A; Jaworski R; Harnett P; Wain G; Crandon A; Cummings M; Horwood K; Obermair A; Wyld D; Nicklin J; Perrin L; Ward B; Davy M; Hall C; Dodd T; Healy T; Pittman K; Henderson D; Hyde S; Miller J; Pierdes J; Blomfield P; Challis D; McIntosh R; Parker A; Rome R; Allen D; Grant P; Laurie R; Robbie M; Healy D, 2007, 'Recreational physical activity and epithelial ovarian cancer: A case-control study, systematic review, and meta-analysis', Cancer Epidemiology Biomarkers and Prevention, 16, pp. 2321 - 2330, http://dx.doi.org/10.1158/1055-9965.EPI-07-0566
McKinley JM; Weideman PC; Jenkins MA; Friedlander ML; Hopper JL; McLachlan SA; Lindeman GJ; Phillips KA, 2007, 'Prostate screening uptake in Australian BRCA1 and BRCA2 carriers', Hereditary Cancer in Clinical Practice, 5, pp. 161 - 163
Colleoni M; Gelber S; Simoncini E; Pagani O; Gelber RD; Price KN; Castiglione-Gertsch M; Coates AS; Goldhirsch A; Thürlimann B; Castiglione M; Collins JP; Cortés Funes H; Green M; Hiltbrunner A; Holmberg SB; Hossfeld DK; Láng I; Lindtner J; Paganetti F; Rudenstam CM; Stahel R; Senn HJ; Veronesi A; Egli G; Rabaglio M; Studer R; Ruepp B; Maibach R; Marbot E; Strausak M; Gelber R; Cole B; Regan M; Zahrieh D; Sun Z; Bernhard J; Hürny C; Gusterson B; Viale G; Blacher L; Celano J; Isley M; Hinkle R; Lippert S; Scott K; Crivellari D; Monfardini S; Galligioni E; Magri MD; Buonadonna A; Massarut S; Rossi C; Candiani E; Carbone A; Volpe R; Roncadin M; Arcicasa M; Coran F; Morassut S; Marini G; Marpicati P; Braga M; Grigolato P; Lucini L; Martinelli G; Orlando L; Nolè F; Torrisi R; De Pas T; de Braud F; Cinieri S; Peccatori F; Luini A; Orecchia R; Renne G; Costa A; Zurrida S; Veronesi P; Sacchini V; Galimberti V; Intra M; Veronesi U; Ravaioli A; Tassinari D; Oliverio G; Barbanti F; Rinaldi P; Pini E; Drudi G; Antimi M; Minelli M; Bellini V; Porzio R; Pernazza E; Santeusanio G; Spagnoli LG; Foladore S; Foghin L, 2007, 'Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: Results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93', Annals of Oncology, 18, pp. 1177 - 1184, http://dx.doi.org/10.1093/annonc/mdm091
Easton DF; Pooley KA; Dunning AM; Pharoah PDP; Thompson D; Ballinger DG; Struewing JP; Morrison J; Field H; Luben R; Wareham N; Ahmed S; Healey CS; Bowman R; Meyer KB; Haiman CA; Kolonel LK; Henderson BE; Le Marchand L; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Eccles D; Evans DG; Peto J; Fletcher O; Johnson N; Seal S; Stratton MR; Rahman N; Chenevix-Trench G; Bojesen SE; Nordestgaard BG; Axelsson CK; Garcia-Closas M; Brinton L; Chanock S; Lissowska J; Peplonska B; Nevanlinna H; Fagerholm R; Eerola H; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Cox DG; Hall P; Wedren S; Liu J; Low YL; Bogdanova N; Schürmann P; Dörk T; Tollenaar RAEM; Jacobi CE; Devilee P; Klijn JGM; Sigurdson AJ; Doody MM; Alexander BH; Zhang J; Cox A; Brock IW; MacPherson G; Reed MWR; Couch FJ; Goode EL; Olson JE; Meijers-Heijboer H; Van Den Ouweland A; Uitterlinden A; Rivadeneira F; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Hopper JL; McCredie M; Southey M; Giles G; Schroen C; Justenhoven C; Brauch H; Hamann U; Ko YD; Spurdle AB; Beesley J; Chen X; Mannermaa A; Kosma VM; Kataja V; Hartikainen J; Day NE, 2007, 'Genome-wide association study identifies novel breast cancer susceptibility loci', Nature, 447, pp. 1087 - 1093, http://dx.doi.org/10.1038/nature05887
Friedlander M; Hancock KC; Benigno B; Rischin D; Messing M; Stringer CA; Tay EH; Kathman S; Matthys G; Lager JJ, 2007, 'Pazopanib (GW786034) is active in women with advanced epithelial ovarian, fallopian tube and peritoneal cancers: Initial results of a phase II study', Journal of Clinical Oncology, 25, pp. 5561 - 5561, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.5561
Hogg R; Scurry JP; Kim SN; Friedlander ML; Hacker NF, 2007, 'Microinvasion links ovarian serous borderline tumour and grade 1 invasive carcinoma', Gynecologic Oncology, 106, pp. 44 - 51
Clarke S; Goldstein D; Mitchell P; Michael M; Beale P; Friedlander ML, 2007, 'Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy', Clinical Colorectal Cancer, 6, pp. 578 - 582
Friedlander ML; Buck MD; Wyld D; Findlay M; Fitzharris B; De Souza PL; Davies TM; Kalimi G; Allan S; Perez DM; Harnett PH, 2007, 'Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer', International Journal of Gynecological Cancer, 17, pp. 350 - 358
Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135
Bennett BK; Goldstein D; Friedlander ML; Hickie IB; Lloyd AR, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: A qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135
Phillips KA; Jenkins MA; Lindeman GJ; Mclachlan SA; Mckinley JM; Weideman PC; Hopper JL; Friedlander ML, 2006, 'Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: A prospective cohort study', Clinical Genetics, 70, pp. 198 - 206, http://dx.doi.org/10.1111/j.1399-0004.2006.00665.x
Dawson S; McKinley J; Jenkins M; McLachlan S; Lindeman G; Friedlander M; Hopper J; Phillips K, 2006, 'Cancer risk management practices of non-carriers within BRCA1/2 mutation positive families in the Kathleen Cunningham Consortium for Research into Familial Breast Cancer (kConFab)', Journal of Clinical Oncology, 24, pp. 1020 - 1020, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.1020
Lutty GA; Chan-Ling T; Phelps DL; Adamis AP; Berns KI; Chan CK; Cole CH; D'Amore PA; Das A; Deng WT; Dobson V; Flynn JT; Friedlander M; Fulton A; Good WV; Grant MB; Hansen R; Hauswirth WW; Hardy RJ; Hinton DR; Hughes S; McLeod DS; Palmer EA; Patz A; Penn JS; Raisler BJ; Repka MX; Saint-Geniez M; Shaw LC; Shima DT; Smith BT; Smith LEH; Tahija SG; Tasman W; Trese MT, 2006, 'Proceedings of the Third International Symposium on Retinopathy of Prematurity: An update on ROP from the lab to the nursery (November 2003, Anaheim, California)', Molecular Vision, 12, pp. 532 - 580
Harrison ML; Hoskins P; Du Bois A; Quinn M; Rustin GJS; Ledermann JA; Baron-Hay S; Friedlander ML, 2006, 'Small cell of the ovary, hypercalcemic type - Analysis of combined experience and recommendation for management. A GCIG study', Gynecologic Oncology, 100, pp. 233 - 238, http://dx.doi.org/10.1016/j.ygyno.2005.10.024
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR; Adams J; Baum M; Buzdar A; Cella D; Coleman R; Constenla M; Cuzick J; Distler W; Dowset M; Eastell R; Fallowfield LJ; Forbes J; George WD; Gray J; Guastalla JP; Hellmund R; Hoctin-Boes G; Houghton J; Williams N; Howell A; Klijn JGM; Locker GY; Mackey J; Mansel RE; Nabholtz JM; Naglkalnai T; Nicolucci A; Nylen U; Sainsbury R; Sapunar F; Suarez-Mendez VJ; Tobias JS; Friedlander M; Richardson G; Makar A; Neven P; Mention J; Distler DW; Eiermann W; Mouritis M; Wamsteker ; Campos O; Candeias OR; Landers G; Llombart A; Menjon S; Repolle´s M; Lindahl B; Ingvar C; Bharbra K; Bjornsson S; Charnock F; Cutner A; De Bono M; Evans-Jones J; Glass M; Holt S; Jones A; Kremer ; O'Donovan P; Omara-Boto TA; Onwude J; Phillips K; Price J; Samtaney N; Seif M; Doe A; Foster E; Woolas R; Buyse M; Wale C; Margolese R; Body JJ, 2006, 'The ATAC ('Arimidex', tamoxifen, alone or in combination) adjuvant breast cancer trial: First results of the endometrial sub-protocol following 2 years of treatment', Human Reproduction, 21, pp. 545 - 553, http://dx.doi.org/10.1093/humrep/dei322
Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander ML; Tucker K, 2006, 'A randomised controlled trial of a decision aid for women at increased risk of ovarian cancer', Medical Decision Making, 26, pp. 360 - 372
Mitchell P; Goldstein D; Beale P; Friedlander ML; Zalcberg J; White S; Thomson JA; Clarke S; Michael M, 2006, 'Addition of Gabapentin to a Modified FOLFOX Regimen Does Not Reduce Oxaliplatin-Induced Neurotoxicity', Clinical Colorectal Cancer, 6, pp. 146 - 151
Aghmesheh M; Suo Z; Friedlander ML; Nesland J; Kaern J; Stewart MP; Dorum A; Tucker K; Buckley MF, 2006, 'Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas', Pathology, 38, pp. 145 - 151
Goldstein D; Bennett BK; Friedlander ML; Davenport TA; Hickie IB; Lloyd AR, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study', BMC Cancer, 6, pp. 240 - 240, http://dx.doi.org/10.1186/1471-2407-6-240
Crockford G; Linger R; Hockley S; Dudakia D; Johnson L; Huddart R; Tucker K; Friedlander ML; Phillips KA; Hogg DW; Jewett M; Lohynska R; Daugaard G; Richard S; Chompret A; Bonaiti-Pellie C; Heidenreich A; Albers P; Olah E; Geczi L; Bodrogi I; Ormiston W; Daly P; Guilford P; Fossa SD; Heimdal K; Tjulandin S; Liubchenko L; Stoll H; Weber W; Forman D; Oliver T; Einhorn L; McMaster M; Kramer J; Greene M; Weber B; Nathanson K; Cortessis V; Easton D; Bishop D; Stratton M; Rapley EA, 2006, 'Genome-wide linkage screen for testicular germ cell tumour susceptibility loci', Human Molecular Genetics, 15, pp. 443 - 451
Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2006, 'Oxaliplatin and axonal Na+ channel function in vivo', Clinical Cancer Research, 12, pp. 4481 - 4484
Martin AC; Friedlander ML; Kiernan MC, 2006, 'Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinoma', Journal of Clinical Neuroscience, 13, pp. 595 - 598
Phillips K; Jenkins M; Lindeman G; McLachlan S; McKinley J; Weideman P; Hopper J; Friedlander M, 2006, 'Risk management practices of Australasian BRCA1 and BRCA2 mutation carriers', European Journal of Cancer Supplements, 4, pp. 71 - 71, http://dx.doi.org/10.1016/s1359-6349(06)80114-x
Phillips KA; Milne RL; Buys S; Friedlander ML; Ward JH; McCredie MRE; Giles GG; Hopper JL, 2005, 'Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry', Journal of Clinical Oncology, 23, pp. 4679 - 4686, http://dx.doi.org/10.1200/JCO.2005.03.002
Kaern J; Aghmesheh M; Nesland JM; Danielsen HE; Sandstad B; Friedlander M; Tropé C, 2005, 'Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?', International Journal of Gynecological Cancer, 15, pp. 1014 - 1022, http://dx.doi.org/10.1111/j.1525-1438.2005.00185.x
Loi S; Milne RL; Friedlander ML; McCredie MRE; Giles GG; Hopper JL; Phillips KA, 2005, 'Obesity and outcomes in premenopausal and postmenopausal breast cancer', Cancer Epidemiology Biomarkers and Prevention, 14, pp. 1686 - 1691, http://dx.doi.org/10.1158/1055-9965.EPI-05-0042
Mitchell P; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; Clarke S; White S, 2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC)', Journal of Clinical Oncology, 23, pp. 3581 - 3581, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3581
Goldstein D; Mitchell P; Friedlander ML; Michael M; Beale P; Zalcberg JR; White S; Clarke SJ, 2005, 'Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients', British Journal of Cancer, 92, pp. 832 - 837, http://dx.doi.org/10.1038/sj.bjc.6602426
Aghmesheh M; Edwards LS; Clarke CL; Byth K; Katzenellenbogen B; Russell PJ; Friedlander ML; Tucker K; de Fazio A, 2005, 'Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas', Gynecologic Oncology, 97, pp. 16 - 25, http://www.sciencedirect.com/science/article/B6WG6-4FDMYCP-5/2/f127ac58f5e70d17372bc0c7d403bfc7
Thewes B; Meiser B; Taylor AJ; Phillips KA; Pendlebury S; Capp A; Dalley D; Goldstein D; Baber R; Friedlander ML, 2005, 'Fertility - and Menoapuse-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer', Journal of Clinical Oncology, 23, pp. 5155 - 5165
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Friedlander ML; Andrews L; Franklin J, 2005, 'Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer', Psycho - Oncology, 14, pp. 249 - 261
Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, 32, pp. 51 - 60
Phillips KA; Butow P; Chang J; Weideman P; Price M; McLachlan S; Lindeman G; Mckay M; Friedlander ML; Hopper JL; Stewart A, 2005, 'Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort', Familial Cancer, 4, pp. 105 - 113
Nathanson K; Kanetsky P; Hawes R; Vaughn D; Letrero R; Tucker K; Friedlander ML; Phillips KA; Hogg DW; Jewett M; Lohynska R; Daugaard G; Richard S; Chompret A; Bonati-Pellie C; Heidenreich A; Olah E; Geczi L; Bodrogi I; Ormiston W; Daly P; Oosterhuis J; Gillis A; Looijenga L; Guilford P; Fossa SD; Heimdal K; Tjulandin S; Liubchenko L; Stoll H; Weber W; Huddart R; Crockford G; Forman D; Oliver D; Einhorn L; Weber B; McMaster M; Greene M; Pike M; Cortessis V; Schwartz S; Bishop D; Easton D; Stratton M; Kramer J; Chen CW; Rapley EA, 2005, 'The Y deletion gr/gr and susceptibility to testicular germ cell tumor', American Journal of Human Genetics, 77, pp. 1034 - 1043
Thewes B; Meiser B; Duric V; Stockler M; Taylor AJ; Stuart-Harris R; Links MR; Wilcken NW; McLachlan S; Phillips KA; Beith J; Boyle FM; Friedlander ML, 2005, 'What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?', Lancet Oncology, 6, pp. 581 - 588
Aghmesheh M; Friedlander M; Russell PJ; Edwards L; Yang J-L; Kconfab K; Nesland JM; Danielson H; Kaern J; Tucker KM, 2004, 'BRCA1 mutation site may associate with nuclear DNA content in BRCA1-associated ovarian carcinomas', Journal of Clinical Oncology, 22, pp. 5040 - 5040, http://dx.doi.org/10.1200/jco.2004.22.90140.5040
Aghmesheh M; Friedlander M; Russell PJ; Edwards L; Yang J-L; Kconfab K; Nesland JM; Danielson H; Kaern J; Tucker KM, 2004, 'BRCA1 mutation site may associate with nuclear DNA content in BRCA1-associated ovarian carcinomas', Journal of Clinical Oncology, 22, pp. 5040 - 5040, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.5040
Loi S; Milne RL; Friedlander ML; McCredie MRE; Giles GG; Hopper JL; Phillips K-A, 2004, 'The impact of obesity on outcomes in a population-based cohort of women with early-onset breast cancer', Journal of Clinical Oncology, 22, pp. 9540 - 9540, http://dx.doi.org/10.1200/jco.2004.22.90140.9540
Loi S; Milne RL; Friedlander ML; McCredie MRE; Giles GG; Hopper JL; Phillips K-A, 2004, 'The impact of obesity on outcomes in a population-based cohort of women with early-onset breast cancer', Journal of Clinical Oncology, 22, pp. 9540 - 9540, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.9540
Rischin D; Phillips KA; Friedlander ML; Harnett P; Quinn MA; Richardson G; Martin A, 2004, 'A Phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer', Gynecologic Oncology, 93, pp. 417 - 421
Hogg R; Friedlander ML, 2004, 'Biology of Epithelial Ovarian cancer: Implications for Screening Women at High Genetic Risk', Journal of Clinical Oncology, 22, pp. 1315 - 1327
Daly EB; Chen GW; Sun L; Friedlander ML; Goldstein D; Beer D; Chesterman CN; Hogg PJ, 2004, 'Blood level of phosphoglycerate kinase does not correlate with presenceor extent of tumor', International Journal of Biological Markers, 19, pp. 170 - 172
Aghmesheh M; Nesland J; Kaern J; Dorum A; Edwards LS; Byth K; Friedlander ML; Jackson P; Tucker K; Russell PJ, 2004, 'No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers', Gynecologic Oncology, 95, pp. 430 - 436, http://www.sciencedirect.com/science/article/B6WG6-4DXB995-1/2/ed6c7284e0c7d1c30ad49018f2a9cb0d
Webster GJ; Kurtovic J; Singh-Grewal I; Friedlander ML; Riordan SM, 2004, 'Prevention of hepatotoxicity but loss of antimelanoma effect withcombined fotemustine and anti-oxidant treatment', Internal Medicine Journal, 34, pp. 298 - U2
Phillips KA; Milne RL; Friedlander ML; Jenkins MA; Mccredie M; Giles GG; Hopper JL, 2004, 'Prognosis of Premenopausal Breast Cancer and Childbirth Prior to Diagnosis', Journal of Clinical Oncology, 22, pp. 699 - 705
Rapley EA; Hockley S; Warren W; Johnson L; Huddart R; Crockford G; Forman D; Leahy M; Oliver D; Tucker K; Friedlander ML; Phillips KA; Hogg D; Jewett M; Lohynska R; Daugaard G; Richard S; Heidenreich A; Geczi L; Bodrogi I; Olah E; Ormiston W; Daly P; Looijenga L; Guilford P; Aass N; Fossa SD; Heimdal K; Tjulandin S; Liubchenko L; Stoll H; Weber W; Einhorn L; Weber B; McMaster M; Greene M; Bishop D; Easton D; Stratton M, 2004, 'Somatic mutations of KIT in familial testicular germ cell tumours', British Journal of Cancer, 90, pp. 2397 - 2401
Meiser B; Tucker M; Andrews L; Tucker K; Friedlander ML; Muir A, 2004, 'The feasibility of women at high risk for breast cancer participating in chemoprevention trials: An attitudinal study', Journal of Psychosocial Oncology, 22, pp. 31 - 45
Back to profile page
https://orcid.org/0000-0003-3090-795X